Acquired Factor VIII deficiency: Rapid and complete remission after immunosuppressive therapy with high dose cyclophosphamide and Rituximab.

被引：0
|
作者：
Tamponi, G [1 ]
Schinco, P [1 ]
Borchiellini, A [1 ]
Valpreda, A [1 ]
Pollio, B [1 ]
Boccadoro, M [1 ]
机构：
[1] Univ Turin, I-10124 Turin, Italy
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3882
引用
收藏
页码：101B / 101B
页数：1
相关论文
共 50 条
  • [21] Sequential therapy with fludarabine, high dose cyclophosphamide, and rituximab induces a high incidence of complete response in patients with chronic lymphocytic leukemia (CLL).
    Lamanna, N
    Weiss, MA
    Maslak, PG
    Gencarelli, AN
    Scheinberg, DA
    Horgan, D
    BLOOD, 2003, 102 (11) : 440A - 440A
  • [22] Reduction of acquired high titer factor VIII antibodies by extracorporeal antibody-based immunoadsorption without additional immunosuppressive therapy
    Toepfer, M
    Rommel, F
    Sitter, T
    Spannagl, M
    Held, E
    Schramm, W
    Schiffl, H
    THROMBOSIS AND HAEMOSTASIS, 1998, 80 (06) : 1035 - 1036
  • [23] FACTOR-VIII INHIBITORS IN HEMOPHILIA - RAPID AND SUCCESSFUL INDUCTION OF IMMUNOTOLERANCE AFTER EARLY AND CONTINUOUS HIGH-DOSE FACTOR-VIII
    KREUZ, W
    EHRENFORTH, S
    AUERSWALD, G
    MENTZER, D
    BEEG, T
    KLARMANN, D
    FUNK, M
    BECKER, S
    STEINER, JJ
    SCHARRER, I
    KORNHUBER, B
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1101 - 1101
  • [24] No added benefit from high-dose cyclophosphamide stem cell mobilization in multiple myeloma in first complete remission after bortezomib-based induction therapy
    Baptista, P.
    Chorao, P.
    Henriques, M.
    Pardal, A. A.
    Monteiro, P.
    Machado, I.
    Teixeira, S.
    Goncalves, L.
    Bergantim, R.
    Aguiar, E.
    Pires, J. C.
    Trigo, F.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 399 - 400
  • [25] Complete clinical remission after high-dose immune suppression and autologous hematopoietic stem cell transplantation in severe Crohn's disease refractory to immunosuppressive and immunomodulator therapy
    Rizzo, A
    Montalbano, L
    Casá, A
    Cottone, M
    INFLAMMATORY BOWEL DISEASES, 2004, 10 (06) : 892 - 894
  • [26] Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia
    Brodsky, RA
    Sensenbrenner, LL
    Smith, BD
    Dorr, D
    Seaman, PJ
    Lee, SM
    Karp, JE
    Brodsky, I
    Jones, RJ
    ANNALS OF INTERNAL MEDICINE, 2001, 135 (07) : 477 - 483
  • [27] Rapid Acquisition of Immunologic Tolerance to Factor VIII and Disappearance of Anti-factor VIII IgG4 After Prophylactic Therapy in a Hemophilia A Patient With High-titer Factor VIII Inhibitor
    Moorehead, Paul C.
    Thibeault, Lisa
    Tuttle, Angie
    Grabell, Julie
    Dwyre, Louise
    Silva, Mariana
    James, Paula
    Lillicrap, David
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2015, 37 (04) : E220 - E222
  • [28] Acquired factor X deficiency in patients with AL amyloidosis: Incidence, bleeding manifestations, and response to high dose therapy.
    Choufani, EB
    Sanchorawala, V
    Skinner, M
    Wright, DG
    Seldin, DC
    BLOOD, 2000, 96 (11) : 534A - 534A
  • [29] Rituximab maintenance therapy achieves a long term remission in a patient with aggressive lymphoma who relapsed after high dose chemotherapy.
    Weide, R
    Heymanns, J
    Koeppler, H
    BLOOD, 2003, 102 (11) : 303B - 303B
  • [30] Rapid relapse after complete remission of metastasized Merkel cell carcinoma by high-dose polychemotherapy and autologous bone marrow transplantation
    Waldmann, V
    Jaeckel, A
    Deichmann, M
    Bock, M
    Hegenbart, U
    Goldschmidt, H
    Hartschuh, W
    Naeher, H
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 112 (04) : 606 - 606
12345